Knowledge, Attitude and Practices Regarding HPV Vaccination among Undergraduate and Postgraduate Dental Students in Chennai
Journal of Pharmaceutical Research International,
Page 95-100
DOI:
10.9734/jpri/2020/v32i1730672
Abstract
Background: It is important for dental students to be aware of the HPV vaccination as they are prone to cervical cancer caused due to HPV 16 and 18. HPV can be transmitted through saliva from the patient's oral cavity to the dentist. To evaluate the knowledge, attitude and practices regarding HPV vaccination among dental students in Chennai.
Materials and Methods: A self-administered questionnaire was prepared to evaluate the knowledge, attitude and practices regarding HPV vaccination. The questionnaire was circulated among 150 students.
Results: 90 students were undergraduates and 60 were postgraduates, p<0.05. 72.7% of the students were aware of HPV vaccination. 45.5% of the students were aware that HPV vaccination is administered against cervical cancer. Only 30% of the students were immunised against HPV.
Conclusion: Within the limitations of the study it was found that most of the students were aware of HPV vaccination, although very few were immunised with HPV vaccination.
Keywords:
- Cervical cancer
- HPV
- vaccination
How to Cite
Baskar, K., & Lakshmi, T. (2020). Knowledge, Attitude and Practices Regarding HPV Vaccination among Undergraduate and Postgraduate Dental Students in Chennai. Journal of Pharmaceutical Research International, 32(17), 95-100. https://doi.org/10.9734/jpri/2020/v32i1730672
References
Forouzanfar MH, Foreman KJ, Delossantos AM, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: A systematic analysis. Lancet. 2011; 378:1461–1484.
Vallikad E. Cervical cancer: the Indian perspective. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006;95(1): 215–33.
Gan DEH, Dahlui M. Cervical screening uptake and its predictors among rural women in Malaysia. Singapore Med J. 2013;54:163–168.
Patterson B, Domanik R, Wernke P, et al. Molecular biomarker–based screening for early detection of cervical cancer. Acta Cytologica. 2001;45:36–47.
Kim CJ, Park TC, Park JS. Efficacy of human papillomavirus vaccines including cross protection: A review of recent evidence. Taehan Sanbuinkwa Hakhoe Chapchi. 2010;53:103–118.
Raychaudhuri S, Mandal S. Current status of Knowledge, Attitude and Practice (KAP) and screening for cervical cancer in countries at different levels of development. Asian Pac J Cancer Prev. 2012;13:4221–4227.
Riedesel JM, Rosenthal SL, Zimet GD, et al. Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol. 2005;18:391–398.
Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer. 2008; 113:3036–3046.
Dayyani F, Etzel CJ, Liu M, et al, Meta-analysis of the impact of Human Papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol. 2010;2:15.
Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29: 4294–4301.
Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348: 518–527.
Rajiah K, Maharajan MK, Fang Num KS, et al. Knowledge about human papillomavirus and cervical cancer: Predictors of HPV vaccination among dental students. Asian Pac J Cancer Prev. 2017;18:1573–1579.
Mann SK, Kingsley K. Human Papillomavirus (HPV) Vaccine Knowledge, Awareness and Acceptance among Dental Students and Post-Graduate Dental Residents. Dent J. 2020;8.
DOI: 10.3390/dj8020045
Rutkoski H, Fowler B, Mooney R, et al. Pilot test of survey to assess dental and dental hygiene student human papillomavirus-related oropharyngeal cancer knowledge, perceptions, and clinical practices. J Cancer Educ. 2018;33: 907–914.
Kepka D, Rutkoski H, Pappas L, et al. US oral health students’ willingness to train and administer the HPV vaccine in dental practices. Prev Med Rep. 2019;15:100957.
Harris KL, Tay D, Kaiser D, et al. The perspectives, barriers, and willingness of Utah dentists to engage in Human Papillomavirus (HPV) vaccine practices. Hum Vaccin Immunother. 2020;16:436–444.
Tan YY, Hesham R, Qodriyah HMS. Knowledge and attitude of university students in health sciences on the prevention of cervical cancer. Med J Malaysia. 2010;65:53–57.
Rashwan HH, Saat NZNM, Abd Manan DN. Knowledge, attitude and practice of malaysian medical and pharmacy students towards human papillomavirus vaccination. Asian Pac J Cancer Prev. 2012;13:2279–2283.
Wong LP. Young multiethnic women’s attitudes toward the HPV vaccine and HPV vaccination. Int J Gynaecol Obstet. 2008; 103:131–135.
Wong LP, Sam I-C. Ethnically diverse female university students’ knowledge and attitudes toward human papillomavirus (HPV), HPV vaccination and cervical cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2010;148:90–95.
Bingham A, Drake JK, LaMontagne DS. Sociocultural issues in the introduction of human papillomavirus vaccine in low-resource settings. Arch Pediatr Adolesc Med. 2009;163:455–461.
Villa LL, Costa RLR, Petta CA, et al,. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 2005;6:271–278.
Einstein MH, Baron M, Levin MJ, et al. Comparison of the immunogenicity and safety of CervarixTM and Gardasil® human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years. Human Vaccines. 2009;5:705–719.
Bhatla N, Dar L, Rajkumar Patro A, et al. Human papillomavirus-type distribution in women with and without cervical neoplasia in north India. Int J Gynecol Pathol. 2008; 27:426–430.
Das BC, Hussain S, Nasare V, et al. Prospects and prejudices of human papillomavirus vaccines in India. Vaccine. 2008;26:2669–2679.
Francis SA, Nelson J, Liverpool J, et al. Examining attitudes and knowledge about HPV and cervical cancer risk among female clinic attendees in Johannesburg, South Africa. Vaccine. 2010;28:8026–8032.
Thangavelu L, Balusamy SR, Shanmugam R, et al,. Evaluation of the sub-acute toxicity of Acacia catechu Willd seed extract in a Wistar albino rat model. Regul Toxicol Pharmacol. 2020;113:104640.
Uzunlar Ö, Özyer Ş, Başer E, et al. A survey on human papillomavirus awareness and acceptance of vaccination among nursing students in a tertiary hospital in Ankara, Turkey. Vaccine. 2013; 31:2191–2195.
Vallikad E. Cervical cancer: the Indian perspective. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006;95(1): 215–33.
Gan DEH, Dahlui M. Cervical screening uptake and its predictors among rural women in Malaysia. Singapore Med J. 2013;54:163–168.
Patterson B, Domanik R, Wernke P, et al. Molecular biomarker–based screening for early detection of cervical cancer. Acta Cytologica. 2001;45:36–47.
Kim CJ, Park TC, Park JS. Efficacy of human papillomavirus vaccines including cross protection: A review of recent evidence. Taehan Sanbuinkwa Hakhoe Chapchi. 2010;53:103–118.
Raychaudhuri S, Mandal S. Current status of Knowledge, Attitude and Practice (KAP) and screening for cervical cancer in countries at different levels of development. Asian Pac J Cancer Prev. 2012;13:4221–4227.
Riedesel JM, Rosenthal SL, Zimet GD, et al. Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol. 2005;18:391–398.
Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer. 2008; 113:3036–3046.
Dayyani F, Etzel CJ, Liu M, et al, Meta-analysis of the impact of Human Papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol. 2010;2:15.
Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29: 4294–4301.
Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348: 518–527.
Rajiah K, Maharajan MK, Fang Num KS, et al. Knowledge about human papillomavirus and cervical cancer: Predictors of HPV vaccination among dental students. Asian Pac J Cancer Prev. 2017;18:1573–1579.
Mann SK, Kingsley K. Human Papillomavirus (HPV) Vaccine Knowledge, Awareness and Acceptance among Dental Students and Post-Graduate Dental Residents. Dent J. 2020;8.
DOI: 10.3390/dj8020045
Rutkoski H, Fowler B, Mooney R, et al. Pilot test of survey to assess dental and dental hygiene student human papillomavirus-related oropharyngeal cancer knowledge, perceptions, and clinical practices. J Cancer Educ. 2018;33: 907–914.
Kepka D, Rutkoski H, Pappas L, et al. US oral health students’ willingness to train and administer the HPV vaccine in dental practices. Prev Med Rep. 2019;15:100957.
Harris KL, Tay D, Kaiser D, et al. The perspectives, barriers, and willingness of Utah dentists to engage in Human Papillomavirus (HPV) vaccine practices. Hum Vaccin Immunother. 2020;16:436–444.
Tan YY, Hesham R, Qodriyah HMS. Knowledge and attitude of university students in health sciences on the prevention of cervical cancer. Med J Malaysia. 2010;65:53–57.
Rashwan HH, Saat NZNM, Abd Manan DN. Knowledge, attitude and practice of malaysian medical and pharmacy students towards human papillomavirus vaccination. Asian Pac J Cancer Prev. 2012;13:2279–2283.
Wong LP. Young multiethnic women’s attitudes toward the HPV vaccine and HPV vaccination. Int J Gynaecol Obstet. 2008; 103:131–135.
Wong LP, Sam I-C. Ethnically diverse female university students’ knowledge and attitudes toward human papillomavirus (HPV), HPV vaccination and cervical cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2010;148:90–95.
Bingham A, Drake JK, LaMontagne DS. Sociocultural issues in the introduction of human papillomavirus vaccine in low-resource settings. Arch Pediatr Adolesc Med. 2009;163:455–461.
Villa LL, Costa RLR, Petta CA, et al,. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 2005;6:271–278.
Einstein MH, Baron M, Levin MJ, et al. Comparison of the immunogenicity and safety of CervarixTM and Gardasil® human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years. Human Vaccines. 2009;5:705–719.
Bhatla N, Dar L, Rajkumar Patro A, et al. Human papillomavirus-type distribution in women with and without cervical neoplasia in north India. Int J Gynecol Pathol. 2008; 27:426–430.
Das BC, Hussain S, Nasare V, et al. Prospects and prejudices of human papillomavirus vaccines in India. Vaccine. 2008;26:2669–2679.
Francis SA, Nelson J, Liverpool J, et al. Examining attitudes and knowledge about HPV and cervical cancer risk among female clinic attendees in Johannesburg, South Africa. Vaccine. 2010;28:8026–8032.
Thangavelu L, Balusamy SR, Shanmugam R, et al,. Evaluation of the sub-acute toxicity of Acacia catechu Willd seed extract in a Wistar albino rat model. Regul Toxicol Pharmacol. 2020;113:104640.
Uzunlar Ö, Özyer Ş, Başer E, et al. A survey on human papillomavirus awareness and acceptance of vaccination among nursing students in a tertiary hospital in Ankara, Turkey. Vaccine. 2013; 31:2191–2195.
-
Abstract View: 421 times
PDF Download: 196 times
Download Statistics
Downloads
Download data is not yet available.
